Literature DB >> 28411897

Management of Essential Hypertension.

Keith C Ferdinand1, Samar A Nasser2.   

Abstract

The treatment of essential hypertension is one of the most critical interventions to decrease cardiovascular morbidity and mortality. The prevalence of hypertension in the US varies across race/ethnicity with African Americans having the highest prevalence and overall less control among racial/ethnic minorities compared with non-Hispanic whites. Therapeutic lifestyle modifications are the bedrock of essential hypertension control, but most patients with hypertension will require pharmacotherapy, usually with multiple medications often in combination. Overall, the principal drug classes recommended as initial pharmacotherapy are thiazide-type diuretics, calcium channel blockers, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  African American; Elderly; Essential hypertension; Goals; Lifestyle modification; Pharmacotherapy

Mesh:

Substances:

Year:  2017        PMID: 28411897     DOI: 10.1016/j.ccl.2016.12.005

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  14 in total

1.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

2.  Association of Thiazide Use in Patients with Hypertension with Overall Fracture Risk: A Population-Based Cohort Study.

Authors:  Cheng-Hsun Chuang; Shun-Fa Yang; Pei-Lun Liao; Jing-Yang Huang; Man-Yee Chan; Chao-Bin Yeh
Journal:  J Clin Med       Date:  2022-06-09       Impact factor: 4.964

Review 3.  Should Renal Inflammation Be Targeted While Treating Hypertension?

Authors:  Sarika Chaudhari; Grace S Pham; Calvin D Brooks; Viet Q Dinh; Cassandra M Young-Stubbs; Caroline G Shimoura; Keisa W Mathis
Journal:  Front Physiol       Date:  2022-06-13       Impact factor: 4.755

4.  Use of lifestyle interventions in primary care for individuals with newly diagnosed hypertension, hyperlipidaemia or obesity: a retrospective cohort study.

Authors:  Julia M Lemp; Meghana Prasad Nuthanapati; Till W Bärnighausen; Sebastian Vollmer; Pascal Geldsetzer; Anant Jani
Journal:  J R Soc Med       Date:  2022-02-17       Impact factor: 18.000

Review 5.  Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US.

Authors:  Donald J Alcendor
Journal:  J Clin Med       Date:  2020-07-30       Impact factor: 4.241

Review 6.  Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

Authors:  Natalia Jorgelina Prado; León Ferder; Walter Manucha; Emiliano Raúl Diez
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

7.  Relationship between neutrophil/lymphocyte ratio and epicardial fat tissue thickness in patients with newly diagnosed hypertension.

Authors:  Mehmet Ali Derya; Vahit Demir; Huseyin Ede
Journal:  J Int Med Res       Date:  2018-01-14       Impact factor: 1.671

Review 8.  State-of-the-Art review: Hypertension practice guidelines in the era of COVID-19.

Authors:  Keith C Ferdinand; Thanh N Vo; Melvin R Echols
Journal:  Am J Prev Cardiol       Date:  2020-07-15

9.  Changes of blood pressure following initiation of physical inactivity and after external addition of pulses to circulation.

Authors:  Marvin A Sackner; Shivam Patel; Jose A Adams
Journal:  Eur J Appl Physiol       Date:  2018-10-22       Impact factor: 3.078

10.  Lifestyle counselling as secondary prevention in patients with minor stroke and transient ischemic attack: study protocol for a randomized controlled pilot study.

Authors:  Jacob Liljehult; Stig Molsted; Tom Møller; Dorthe Overgaard; Lis Adamsen; Mary Jarden; Thomas Christensen
Journal:  Pilot Feasibility Stud       Date:  2020-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.